EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway

Hanaa F B Gaber, Fatma S M Moawed iD, Mohamed K Mahfouz, Esraa S A Ahmed iD, Omayma A R Abo-Zaid iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71801 ↗

At a glance

Journal article in Chemistry & Biodiversity, 2026. Written by Hanaa F B Gaber and 4 co-authors. Institution: Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Benha University, Al-Qalyubia, Egypt. Major MEDLINE topics: Metformin, AMP-Activated Protein Kinases, Diabetes Mellitus, Experimental, Sterol Regulatory Element Binding Protein 1. 59 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Diabetes mellitus (DM) is a common complication among cancer patients, potentially worsening the adverse effects of radiation therapy. This study aimed to evaluate whether pentahydroxy flavone (PHF) and Metformin (MET) could mitigate liver damage associated with streptozotocin (STZ)‐induced diabetes in rats exposed to gamma irradiation (IR). Diabetes was induced in rats by a single dose of STZ (35 mg/kg) and exposure to a cumulative IR dose (4 Gy). Over one month, each treatment group received either PHF (50 mg/kg) or MET (200 mg/kg). Combined treatment with PHF and MET improved lipid profiles, reduced insulin resistance, coupled with diminishing hepatic inflammation (NLRC4) and oxidative stress. Furthermore, co‐administration of PHF and MET modulated the AMPK/ SREBP1c/ SCD1‐related signaling, ameliorating hepatic steatosis and fibrosis. These findings suggest that PHF combined with MET's could serve as an adjuvant therapy alongside MET to protect against liver damage caused by diabetes and gamma radiation.

Subjects

MeSH terms (MEDLINE)

MetforminAMP-Activated Protein KinasesDiabetes Mellitus, ExperimentalSterol Regulatory Element Binding Protein 1LiverOxidative StressGamma RaysAnimalsRatsRats, WistarFlavonoids

Author keywords

AMPK/ SREBP1c/ SCD1diabetes mellitusgamma irradiationmetforminpentahydroxy flavone

Substances

MetforminpeflavitAMP-Activated Protein KinasesSterol Regulatory Element Binding Protein 1Flavonoids

Authors and institutions

  • Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Benha University, Al-Qalyubia, Egypt.
  • Health Radiation Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Radiation Biology Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.

ORCID profiles: Fatma S M Moawed, Esraa S A Ahmed, Omayma A R Abo-Zaid

Cite

APA

Gaber, H. F. B., Moawed, F. S. M., Mahfouz, M. K., Ahmed, E. S. A., & Abo-Zaid, O. A. R. (2026). Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71801

Vancouver

Gaber HFB, Moawed FSM, Mahfouz MK, Ahmed ESA, Abo-Zaid OAR. Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71801

BibTeX
@article{Gaber2026,
  author = {Gaber, Hanaa F B and Moawed, Fatma S M and Mahfouz, Mohamed K and Ahmed, Esraa S A and Abo-Zaid, Omayma A R},
  title = {Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71801}
}
Start for free →